Cel-Sci, Nippon Zeon Co. Ltd. deal

CELI repurchased all remaining rights to its HGP-30 AIDS vaccine from Nippon Zeon for 45,000 shares of CELI stock. Nippon’s remaining rights had consisted of a 10 percent royalty on Pacific Rim sales ...